{
  "docId": "019de077-0326-7579-845c-ff13347b3147",
  "docSlug": "a6759fd47798a8f3f6e744ad8917865e",
  "documentTitle": "Exscientia | Investor Presentation Deck | 93 slides",
  "authorId": "exscientia",
  "authorName": "Exscientia",
  "documentKindSlug": "pitchdeck",
  "documentKindLabel": "Pitch deck",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2024-03-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 83,
  "pageCount": 93,
  "prevPage": 82,
  "nextPage": 84,
  "slideType": "solution",
  "function": "present_solution",
  "density": "overcrowded",
  "nDataPoints": 0,
  "notes": null,
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de077-0326-7579-845c-ff13347b3147/83",
  "deckHref": "/decks/019de077-0326-7579-845c-ff13347b3147",
  "deckJsonHref": "/decks/019de077-0326-7579-845c-ff13347b3147.json",
  "deckAnchorHref": "/decks/019de077-0326-7579-845c-ff13347b3147#slide-83",
  "components": [
    {
      "bbox": {
        "h": 0.15,
        "w": 0.25,
        "x": 0.67,
        "y": 0.67
      },
      "kind": "callout",
      "text": "Synergistic efficacy",
      "attrs": null,
      "subkind": "primary",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "58111838-2b38-4c4e-a78c-3988ed1970f2",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.25,
        "x": 0.08,
        "y": 0.67
      },
      "kind": "callout",
      "text": "Goal was to invent a potent and highly selective allosteric MALT1 inhibitor",
      "attrs": null,
      "subkind": "primary",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "67131ff7-2d89-4479-a35d-ac1952f1417d",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.25,
        "x": 0.37,
        "y": 0.67
      },
      "kind": "callout",
      "text": "Addresses a combination issue common to most MALT1 inhibitors",
      "attrs": null,
      "subkind": "primary",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "e2e2e7cb-82fd-4642-a7cf-df46b7e25092",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.3,
        "w": 0.25,
        "x": 0.67,
        "y": 0.28
      },
      "kind": "list",
      "text": "Efficacy and Dosing: Shown to be effective as both a monotherapy and in combination with ibrutinib (BTKi); Anti-proliferative against primary B-cell lymphoma samples; Predicted half-life suitable for QD administration",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "1cc64ab5-2c63-47da-8c61-3244dd5165c4",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.25,
        "w": 0.25,
        "x": 0.08,
        "y": 0.28
      },
      "kind": "list",
      "text": "Selective and Potent: Design a potent and highly selective MALT1 inhibitor with an allosteric mechanism of action; Clean protease panel selectivity profile",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "5adaa9b6-ba39-46e2-84fe-2f05f37d850e",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.25,
        "w": 0.25,
        "x": 0.37,
        "y": 0.28
      },
      "kind": "list",
      "text": "Therapeutic Index: Demonstrate adequate therapeutic index over potential on mechanism toxicity; Minimise potential drug-drug interactions with combination agents",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "9d90a4ea-eb8f-4065-a405-e860ae3141d2",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.04,
        "w": 0.45,
        "x": 0.07,
        "y": 0.14
      },
      "kind": "title",
      "text": "Developing a differentiated and selective inhibitor",
      "attrs": null,
      "subkind": "action-title",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "e8b7f48c-6648-498c-bb0e-e1b3e8742c3e",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.6,
        "x": 0.07,
        "y": 0.07
      },
      "kind": "title",
      "text": "Precision designed to maximise therapeutic index",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "933caa86-4ee0-4d34-b9d8-99d9a053e1cd",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "AIDA Model",
      "slug": "aida-model",
      "agent": "Storyteller",
      "layer": "slide",
      "matchId": "1dea43d9-5ff6-4cfd-923c-45f63c5975c1",
      "evidence": "The components of the slide, including lists and callouts, aim to grab attention (A), generate interest (I), create desire (D), and encourage action (A) for a potent and highly selective MALT1 inhibitor.",
      "confidence": 0.7
    }
  ],
  "frameworks": [],
  "arcBeats": [],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}